Research Specifications
- Sequence:
- D-Arg-2',6'-Dmt-Lys-Phe-NH2
- CAS:
- 736992-21-5
- Molecular Weight:
- 639.79 Da
- Vial:
- 50mg lyophilized (5× the 10mg vial)
- Purity:
- ≥98% HPLC verified
SS-31 50mg
Elamipretide cardiolipin-binding tetrapeptide
CAS: 736992-21-5
Cardiolipin
Primary target
Szeto 2014
50mg
Bulk vial
~1.25 vials/week at clinical label
Phase 3
Most advanced stage
Stealth BioTx
$296.99In Stock
Buy Now ≥98% Purity Verified Free Shipping $200+ HPLC Tested
Phase 3
Phase 3 trials (Stealth BioTherapeutics)
2024 FDA Complete Response Letter for Barth syndrome. Ongoing development in mitochondrial myopathy, LHON, and dry AMD.
Complementary Compounds
Also Known As
ElamipretideBendaviaMTP-131SS-31Szeto-Schiller peptide 31
Prep & Cycle Schedule
BAC Water
5mL
Final Concentration
10 mg/mL
Per Dose
40 mg (clinical label) = 4 mL · 10 mg = 1 mL
50mg vial covers ~1.25 days at Phase 3 label dose
Published References
- 1.Szeto HH, Birk AV. Serendipity and the discovery of novel compounds that restore mitochondrial plasticity. Clinical Pharmacology & Therapeutics (2014) PMID: 24960521
Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.
Price Comparison
| Supplier | Purity | Price | Shipping |
|---|---|---|---|
| our verified supplier | >98% HPLC | $296.99 | Free over $200 |
| Generic Research Suppliers | Varies (often <95%) | Similar–Higher | Varies |
| Pharmaceutical (Rx only) | Pharmaceutical grade | Not available for research | Rx required |
Buy Peptides Compounds
SS-31 50mg
$296.99